Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial

Research output: Contribution to journal › Journal article › Research › peer-review

Documents

  • ene.14715

    Final published version, 886 KB, PDF document

  • dlt446, dlt446
  • Peter J. Goadsby
  • Uwe Reuter
  • Stephen Silberstein
  • David W. Dodick
  • Fei Xue
  • Feng Zhang
  • Gabriel Paiva Da Silva Lima
  • Sunfa Cheng
  • Daniel D. Mikol
Original languageEnglish
JournalEuropean Journal of Neurology
Volume28
Issue number5
Pages (from-to)1716-1725
Number of pages10
ISSN1351-5101
DOIs
Publication statusPublished - 1 May 2021

ID: 280561349